Catalyst Wire Dossier Catalyst Wire Dossier

WIDAPLIK

telmisartan, amlodipine and indapamide · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WIDAPLIK, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: FDA Approved: WIDAPLIK — Original Application (Azurity Pharmaceuticals, Inc.)

See pricing